Adverum Biotechnologies Inc. buy Truist Financial Co.
Start price
05.09.23
/
50%
€1.62
Target price
05.09.24
€5.60
Performance (%)
-17.28%
Price
20.03.24
€1.38
Summary
This prediction is currently active. The price of Adverum Biotechnologies Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.28%. This prediction currently runs until 05.09.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Adverum Biotechnologies Inc. | - | - |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $6.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat